SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-010422
Filing Date
2021-03-03
Accepted
2021-03-03 07:40:50
Documents
14
Period of Report
2021-03-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kldo-8k_20210303.htm   iXBRL 8-K 39648
2 EX-99.1 kldo-ex991_6.htm EX-99.1 136828
3 GRAPHIC gyb2j0qv2v1u000001.jpg GRAPHIC 9153
  Complete submission text file 0001564590-21-010422.txt   329356

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA kldo-20210303.xsd EX-101.SCH 5772
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE kldo-20210303_lab.xml EX-101.LAB 19459
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kldo-20210303_pre.xml EX-101.PRE 11626
7 EXTRACTED XBRL INSTANCE DOCUMENT kldo-8k_20210303_htm.xml XML 3539
Mailing Address 18 CROSBY DRIVE BEDFORD MA 01730
Business Address 18 CROSBY DRIVE BEDFORD MA 01730 617-674-9000
Kaleido Biosciences, Inc. (Filer) CIK: 0001751299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38822 | Film No.: 21707238
SIC: 2836 Biological Products, (No Diagnostic Substances)